Versant Venture Management »

Repare Therapeutics Ord shares owned by Versant Venture Management

Quarter-by-quarter ownership of Repare Therapeutics Ord (RPTX) shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Repare Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Repare Therapeutics Ord held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repare Therapeutics Ord by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $19M 2.6M 7.30
2023-09-30 $32M 2.6M 12.08
2023-06-30 $28M 2.6M 10.58

More positions owned by Versant Venture Management

RayzeBio Common Stock
CRISPR Therapeutics Common Shares (CRSP)
Repare Therapeutics Common Stock (RPTX)
Gritstone Bio Common Stock (GRTS)
Passage Bio Common Stock (PASG)
Adverum Biotechnologies Common Stock
Aligos Therapeutics Common Stock (ALGS)

View all positions for Versant Venture Management

Top funds holding Repare Therapeutics Ord

BVF
OrbiMed Advisors
Blue Owl Capital Holdings
ARK Investment Management
Versant Venture Management
Redmile Group
Artal Group
Aquilo Capital Management
Logos Global Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Millennium Management
GSA Capital Partners
Bank Of Montreal
D. E. Shaw & Co

View all funds holding Repare Therapeutics Ord